Structured evidence table for Cacao Flavanol Exercise Performance Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Cacao Flavanol Exercise Performance Randomized Trial | It includes increased interferons, tumor necrosis factor, bradykinin, serine proteases, and soluble thrombomodulin, and altered clot lysis times [,,,,], all of which contribute to microvascular and thrombotic disease [,]. | 2 | Munguía Levy (2026) | Effects of Cacao Flavonoids in Long COVID-19 Patients with Chronic Fatigue: FLALOC, a Placebo-Controlled Randomized Clinical Trial |
| Cacao Flavanol Exercise Performance Randomized Trial | A myriad of causes can trigger fatigue, but its development has been strongly associated with post-viral phases of infection. | 2 | Munguía Levy (2026) | Effects of Cacao Flavonoids in Long COVID-19 Patients with Chronic Fatigue: FLALOC, a Placebo-Controlled Randomized Clinical Trial |
| Cacao Flavanol Exercise Performance Randomized Trial | Long COVID-associated fatigue has been causally linked to sustained inflammation and to endothelial and mitochondrial dysfunction. | 2 | Munguía Levy (2026) | Effects of Cacao Flavonoids in Long COVID-19 Patients with Chronic Fatigue: FLALOC, a Placebo-Controlled Randomized Clinical Trial |
| Cacao Flavanol Exercise Performance Randomized Trial | 1 2 3 4 5 6 7 8 Coronavirus disease 2019 (COVID-19) is caused by the acute respiratory syndrome coronavirus 2 (SARS-CoV-2). | 2 | Munguía Levy (2026) | Effects of Cacao Flavonoids in Long COVID-19 Patients with Chronic Fatigue: FLALOC, a Placebo-Controlled Randomized Clinical Trial |
| Cacao Flavanol Exercise Performance Randomized Trial | MetS is a multifactorial condition, with its primary indicators including obesity, hypertension, dyslipidemia, insulin resistance, and hyperglycemia; i.e., a patient who possesses at least 3 of the following parameters is designated with MetS: glucose intolerance, increased levels of triglycerides, augmented waist circumference, low levels of high-density lipoprotein cholesterol (HDL-c), and hypertension [,,]. | 3 | Tomaru Júlia Mayumi (2026) | Beyond Taste: The Impact of Chocolate on Cardiovascular and Steatotic Liver Disease Risk Factors |
| Cacao Flavanol Exercise Performance Randomized Trial | It is possible to develop a close relationship with MetS, metabolic dysfunction-associated steatotic liver disease (MASLD), and CVD [,]. | 3 | Tomaru Júlia Mayumi (2026) | Beyond Taste: The Impact of Chocolate on Cardiovascular and Steatotic Liver Disease Risk Factors |
| Cacao Flavanol Exercise Performance Randomized Trial | MASLD is strongly associated with various conditions, including MetS, and is characterized by the persistence of a chronic inflammatory state detrimental to the organism [,]. | 3 | Tomaru Júlia Mayumi (2026) | Beyond Taste: The Impact of Chocolate on Cardiovascular and Steatotic Liver Disease Risk Factors |
| Cacao Flavanol Exercise Performance Randomized Trial | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Metabolic disorders are increasing sharply due to severe modifications in lifestyle [,,,]. | 3 | Tomaru Júlia Mayumi (2026) | Beyond Taste: The Impact of Chocolate on Cardiovascular and Steatotic Liver Disease Risk Factors |
Source documents